Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Clinical & Experimental Allergy2021Vol. 51(9), pp. 1107–1120
Citations Over TimeTop 1% of 2021 papers
Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, Anastasia Shikhaleva, Aysylu Gamirova, Oleg Blyuss, Nikita Nekliudov, Polina Bugaeva, Margarita Andreeva, Audrey DunnGalvin, Pasquale Comberiati, Christian Apfelbacher, Jon Genuneit, С. Н. Авдеев, Валентина Капустина, Alla Guekht, Victor Fomin, Andrey А. Svistunov, Peter Timashev, V.S. Subbot, Valery V. Royuk, Thomas M. Drake, Sarah Wulf Hanson, Laura Merson, Gail Carson, Peter Horby, Louise Sigfrid, J. T. Scott, Malcolm G. Semple, John O. Warner, Theo Vos, Piero Olliaro, Petr Glybochko, Denis Butnaru
Abstract
Almost half of adults admitted to hospital due to COVID-19 reported persistent symptoms 6 to 8 months after discharge. Fatigue and respiratory symptoms were most common, and female sex was associated with persistent symptoms.
Related Papers
- → Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)(2020)32 cited
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → The COVID-19 conundrum: SARS-CoV-2 is not present in bile(2020)7 cited
- → ChAdOx1 nCoV-19 vaccine for SARS-CoV-2(2020)7 cited